Skip to main content

Advertisement

SpringerLink
Log in

Single- and hypofractionated stereotactic radiosurgery for large (> 2 cm) brain metastases: a systematic review

  • Topic Review
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Purpose

Since frameless stereotactic radiosurgery (SRS) techniques have been recently introduced, hypofractionated SRS (HF-SRS) for large brain metastases (BMs) is gradually increasing. To verify the efficacy and safety of HF-SRS for large BMs, we aimed to perform a systematic review and compared them with SF-SRS.

Methods

We systematically searched the studies regarding SF-SRS or HF-SRS for large (> 2 cm) BM from databases including PubMed, Embase, and the Cochrane Library on July 31, 2018. Biologically effective dose with the α/β ratio of 10 (BED10), 1-year local control (LC), and radiation necrosis (RN) were compared between the two groups, with the studies being weighted by the sample size.

Results

The 15 studies with 1049 BMs that described 1-year LC and RN were included. HF-SRS tended to be performed in larger tumors; however, higher mean BED10 (50.1 Gy10 versus 40.4 Gy10, p < 0.0001) was delivered in the HF-SRS group, which led to significantly improved 1-year LC (81.6 versus 69.0%, p < 0.0001) and 1-year overall survival (55.1 versus 47.2%, p < 0.0001) in the HF-SRS group compared to the SF-SRS group. In contrast, the incidence of radiation toxicity was significantly decreased in the HF-SRS group compared to the SF-SRS group (8.0 versus 15.6%, p < 0.0001).

Conclusion

HF-SRS results in better LC of large BMs while simultaneously reducing RN compared to SF-SRS. Thus, HF-SRS should be considered a priority for SF-SRS in patients with large BMs who are not suitable to undergo surgical resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Jeong WJ, Park JH, Lee EJ, Kim JH, Kim CJ, Cho YH (2015) Efficacy and safety of fractionated stereotactic radiosurgery for large brain metastases. J Korean Neurosurg Soc 58:217–224. https://doi.org/10.3340/jkns.2015.58.3.217

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Shiau CY, Sneed PK, Shu HKG, Lamborn KR, McDermott MW, Chang S, Nowak P, Petti PL, Smith V, Verhey LJ, Ho M, Park E, Wara WM, Gutin PH, Larson DA (1997) Radiosurgery for brain metastases: Relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 37:375–383. https://doi.org/10.1016/S0360-3016(96)00497-X

    Article  CAS  PubMed  Google Scholar 

  3. Breneman JC, Warnick RE, Albright RE Jr, Kukiatinant N, Shaw J, Armin D, Tew J Jr (1997) Stereotactic radiosurgery for the treatment of brain metastases. Results of a single institution series. Cancer 79:551–557

    Article  CAS  Google Scholar 

  4. Matsuo T, Shibata S, Yasunaga A, Iwanaga M, Mori K, Shimizu T, Hayashi N, Ochi M, Hayashi K (1999) Dose optimization and indication of linac radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 45:931–939. https://doi.org/10.1016/S0360-3016(99)00271-0

    Article  CAS  PubMed  Google Scholar 

  5. Gerosa M, Nicolato A, Foroni R, Tomazzoli L, Bricolo A (2005) Analysis of long-term outcomes and prognostic factors in patients with non-small cell lung cancer brain metastases treated by gamma knife radiosurgery. J Neurosurg 102:75–80. https://doi.org/10.3171/jns.2005.102.s_supplement.0075

    Article  PubMed  Google Scholar 

  6. Sheehan J, Kondziolka D, Flickinger J, Lunsford LD (2005) Radiosurgery for patients with recurrent small cell lung carcinoma metastatic to the brain: outcomes and prognostic factors. J Neurosurg 102:247–254. https://doi.org/10.3171/jns.2005.102.s_supplement.0247

    Article  PubMed  Google Scholar 

  7. Muacevic A, Kreth FW, Tonn JC, Wowra B (2004) Stereotactic radiosurgery for multiple brain metastases from breast carcinoma—feasibility and outcome of a local treatment concept. Cancer 100:1705–1711. https://doi.org/10.1002/cncr.20167

    Article  PubMed  Google Scholar 

  8. Selek U, Chang EL, Hassenbusch SJ, Shiu AS, Lang FF, Allen P, Weinberg J, Sawaya R, Maor MH (2004) Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 59:1097–1106. https://doi.org/10.1016/j.ijrobp.2003.12.037

    Article  PubMed  Google Scholar 

  9. Muacevic A, Siebels M, Tonn JC, Wowra B (2005) Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery? World J Urol 23:180–184. https://doi.org/10.1007/s00345-004-0471-3

    Article  PubMed  Google Scholar 

  10. Alexander E 3rd, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, Kooy HM, Loeffler JS (1995) Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87:34–40. https://doi.org/10.1093/jnci/87.1.34

    Article  PubMed  Google Scholar 

  11. Mori Y, Kondziolka D, Flickinger JC, Kirkwood JM, Agarwala S, Lunsford LD (1998) Stereotactic radiosurgery for cerebral metastatic melanoma: Factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 42:581–589. https://doi.org/10.1016/S0360-3016(98)00272-7

    Article  CAS  PubMed  Google Scholar 

  12. Noel G, Simon JM, Valery CA, Cornu P, Boisserie G, Hasboun D, Ledu D, Tep B, Delattre JY, Marsault C, Baillet F, Mazeron JJ (2003) Radiosurgery for brain metastasis: impact of CTV on local control. Radiother Oncol 68:15–21. https://doi.org/10.1016/S0167-8140(03)00207-X

    Article  PubMed  Google Scholar 

  13. Molenaar R, Wiggenraad R, Verbeek-de Kanter A, Walchenbach R, Vecht C (2009) Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis. Br J Neurosurg 23:170–178. https://doi.org/10.1080/02688690902755613

    Article  PubMed  Google Scholar 

  14. van Leeuwen CM, Oei AL, Crezee J, Bel A, Franken NAP, Stalpers LJA, Kok HP (2018) The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies. Radiat Oncol. https://doi.org/10.1186/s13014-018-1040-z

    Article  PubMed  PubMed Central  Google Scholar 

  15. McClelland S 3rd, Ford B, Senatus PB, Frucht SJ, Winfield LM, Yu Q, Du YE, Pullman SL, McKhann GM 2nd, Goodman RR (2009) Typical variations of subthalamic electrode location do not predict limb motor function improvement in Parkinson’s disease. J Clin Neurosci 16:771–778. https://doi.org/10.1016/j.jocn.2008.10.011

    Article  PubMed  Google Scholar 

  16. Aoyama H, Shirato H, Onimaru R, Kagei K, Ikeda J, Ishii N, Sawamura Y, Miyasaka K (2003) Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys 56:793–800. https://doi.org/10.1016/s0360-3016(03)00014-2

    Article  PubMed  Google Scholar 

  17. Ogura K, Mizowaki T, Ogura M, Sakanaka K, Arakawa Y, Miyamoto S, Hiraoka M (2012) Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors. J Neurooncol 109:425–432. https://doi.org/10.1007/s11060-012-0912-6

    Article  CAS  PubMed  Google Scholar 

  18. Feuvret L, Vinchon S, Martin V, Lamproglou I, Halley A, Calugaru V, Chea M, Valery CA, Simon JM, Mazeron JJ (2014) Stereotactic radiotherapy for large solitary brain metastases. Cancer Radiotherapie 18:97–106. https://doi.org/10.1016/j.canrad.2013.12.003

    Article  CAS  PubMed  Google Scholar 

  19. Murai T, Ogino H, Manabe Y, Iwabuchi M, Okumura T, Matsushita Y, Tsuji Y, Suzuki H, Shibamoto Y (2014) Fractionated stereotactic radiotherapy using cyberknife for the treatment of large brain metastases: a dose escalation study. Clin Oncol 26:151–158. https://doi.org/10.1016/j.clon.2013.11.027

    Article  CAS  Google Scholar 

  20. Nagai A, Shibamoto Y, Yoshida M, Wakamatsu K, Kikuchi Y (2014) Treatment of single or multiple brain metastases by hypofractionated stereotactic radiotherapy using helical tomotherapy. Int J Mol Sci 15:6910–6924. https://doi.org/10.3390/ijms15046910

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Kim JW, Park HR, Lee JM, Kim JW, Chung HT, Kim DG, Jung HW, Paek SH (2016) Fractionated stereotactic gamma knife radiosurgery for large brain metastases: a retrospective Single Center Study. PLoS ONE 11(9):e0163304. https://doi.org/10.1371/journal.pone.0163304

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Minniti G, Scaringi C, Paolini S, Lanzetta G, Romano A, Cicone F, Osti M, Enrici RM, Esposito V (2016) Single-fraction versus multifraction (3 x 9 Gy) stereotactic radiosurgery for large (> 2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys 95:1142–1148. https://doi.org/10.1016/j.ijrobp.2016.03.013

    Article  PubMed  Google Scholar 

  23. Navarria P, Pessina F, Cozzi L, Ascolese AM, De Rose F, Fogliata A, Franzese C, Franceschini D, Tozzi A, D’Agostino G, Comito T, Iftode C, Maggi G, Reggiori G, Bello L, Scorsetti M (2016) Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resection. Radiat Oncol. https://doi.org/10.1186/s13014-016-0653-3

    Article  PubMed  PubMed Central  Google Scholar 

  24. Marcrom SR, McDonald AM, Thompson JW, Popple RA, Riley KO, Markert JM, Willey CD, Bredel M, Fiveash JB (2017) Fractionated stereotactic radiation therapy for intact brain metastases. Adv Radiat Oncol 2:564–571. https://doi.org/10.1016/j.adro.2017.07.006

    Article  PubMed  PubMed Central  Google Scholar 

  25. Wiggenraad R, Verbeek-de Kanter A, Mast M, Molenaar R, Kal HB, Lycklama A, Nijeholt G, Vecht C, Struikmans H (2012) Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases. A single centre study. Strahlenther Onkol 188:696–701. https://doi.org/10.1007/s00066-012-0122-3

    Article  CAS  PubMed  Google Scholar 

  26. Kano H, Niranjan A, Kondziolka D, Flickinger JC, Lunsford LD (2009) Stereotactic radiosurgery for pituitary metastases. Surg Neurol 72:248–255. https://doi.org/10.1016/j.surneu.2008.06.003

    Article  PubMed  Google Scholar 

  27. Flannery T, Kano H, Niranjan A, Monaco EA, Flickinger JC, Lunsford LD, Kondziolka D (2010) Stereotactic radiosurgery as a therapeutic strategy for intracranial metastatic prostate carcinoma. J Neurooncol 96:369–374. https://doi.org/10.1007/s11060-009-9966-5

    Article  PubMed  Google Scholar 

  28. Prabhu RS, Press RH, Patel KR, Boselli DM, Symanowski JT, Lankford SP, McCammon RJ, Moeller BJ, Heinzerling JH, Fasola CE, Asher AL, Sumrall AL, Buchwald ZS, Curran WJ Jr, Shu HG, Crocker I, Burri SH (2017) Single-fraction stereotactic radiosurgery (SRS) alone versus surgical resection and SRS for large brain metastases: a multi-institutional analysis. Int J Radiat Oncol Biol Phys 99:459–467. https://doi.org/10.1016/j.ijrobp.2017.04.006

    Article  PubMed  Google Scholar 

  29. Cummings M, Youn P, Bergsma DP, Usuki KY, Walter K, Sharma M, Okunieff P, Schell MC, Milano MT (2018) Single-fraction radiosurgery using conservative doses for brain metastases: durable responses in select primaries with limited toxicity. Neurosurgery 83:437–444. https://doi.org/10.1093/neuros/nyx427

    Article  PubMed  Google Scholar 

  30. Wolf A, Kvint S, Chachoua A, Pavlick A, Wilson M, Donahue B, Golfinos JG, Silverman J, Kondziolka D (2018) Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery. J Neurosurg 128:23–31. https://doi.org/10.3171/2016.10.Jns161036

    Article  PubMed  Google Scholar 

  31. Kalkanis SN, Kondziolka D, Gaspar LE, Burri SH, Asher AL, Cobbs CS, Ammirati M, Robinson PD, Andrews DW, Loeffler JS, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Ryken TC, Linskey ME (2010) The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:33–43. https://doi.org/10.1007/s11060-009-0061-8

    Article  PubMed  Google Scholar 

  32. Lehrer EJ, Peterson JL, Zaorsky NG, Brown PD, Sahgal A, Chiang VL, Chao ST, Sheehan JP, Trifiletti DM (2019) Single versus multifraction stereotactic radiosurgery for large brain metastases: an international meta-analysis of 24 trials. Int J Radiat Oncol Biol Phys 103:618–630. https://doi.org/10.1016/j.ijrobp.2018.10.038

    Article  PubMed  Google Scholar 

  33. Masucci GL (2018) Hypofractionated radiation therapy for large brain metastases. Front Oncol. https://doi.org/10.3389/fonc.2018.00379

    Article  PubMed  PubMed Central  Google Scholar 

  34. Williams BJ, Suki D, Fox BD, Pelloski CE, Maldaun MV, Sawaya RE, Lang FF, Rao G (2009) Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. J Neurosurg 111:439–448. https://doi.org/10.3171/2008.11.JNS08984

    Article  PubMed  Google Scholar 

  35. Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77:996–1001. https://doi.org/10.1016/j.ijrobp.2009.06.006

    Article  PubMed  Google Scholar 

  36. Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, Romano A, Enrici RM (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol. https://doi.org/10.1186/1748-717x-6-48

    Article  PubMed  PubMed Central  Google Scholar 

  37. Nedzi LA, Kooy H, Alexander E 3rd, Gelman RS, Loeffler JS (1991) Variables associated with the development of complications from radiosurgery of intracranial tumors. Int J Radiat Oncol Biol Phys 21:591–599. https://doi.org/10.1016/0360-3016(91)90675-t

    Article  CAS  PubMed  Google Scholar 

  38. Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB (2006) 12 GY gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64:419–424. https://doi.org/10.1016/j.ijrobp.2005.07.980

    Article  PubMed  Google Scholar 

  39. Santacroce A, Kamp MA, Budach W, Hanggi D (2013) Radiobiology of radiosurgery for the central nervous system. Biomed Res Int 2013:362761. https://doi.org/10.1155/2013/362761

    Article  PubMed  PubMed Central  Google Scholar 

  40. Jiang XS, Xiao JP, Zhang Y, Xu YJ, Li XP, Chen XJ, Huang XD, Yi JL, Gao L, Li YX (2012) Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters. Radiat Oncol. https://doi.org/10.1186/1748-717x-7-36

    Article  PubMed  PubMed Central  Google Scholar 

  41. Minniti G, D’Angelillo RM, Scaringi C, Trodella LE, Clarke E, Matteucci P, Osti MF, Ramella S, Enrici RM, Trodella L (2014) Fractionated stereotactic radiosurgery for patients with brain metastases. J Neurooncol 117:295–301. https://doi.org/10.1007/s11060-014-1388-3

    Article  CAS  PubMed  Google Scholar 

  42. Chon H, Yoon K, Lee D, Kwon DH, Cho YH (2019) Single-fraction versus hypofractionated stereotactic radiosurgery for medium-sized brain metastases of 2.5 to 3 cm. J Neurooncol 145:49–56. https://doi.org/10.1007/s11060-019-03265-1

    Article  PubMed  Google Scholar 

  43. Schlienger M, Nataf F, Huguet F, Pene F, Foulquier JN, Orthuon A, Roux FX, Touboul E (2010) Hypofractionated stereotactic radiotherapy for brain metastases. Cancer Radiother 14:119–127. https://doi.org/10.1016/j.canrad.2009.10.004

    Article  CAS  PubMed  Google Scholar 

  44. Larsson B, Leksell L, Rexed B, Sourander P, Mair W, Andersson B (1958) High-energy proton beam as a neurosurgical tool. Nature 182:1222–1223. https://doi.org/10.1038/1821222a0

    Article  CAS  PubMed  Google Scholar 

  45. Zhao W, Robbins ME (2009) Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications. Curr Med Chem 16:130–143. https://doi.org/10.2174/092986709787002790

    Article  CAS  PubMed  Google Scholar 

  46. Panganiban RA, Mungunsukh O, Day RM (2013) X-irradiation induces ER stress, apoptosis, and senescence in pulmonary artery endothelial cells. Int J Radiat Biol 89:656–667. https://doi.org/10.3109/09553002.2012.711502

    Article  CAS  PubMed  Google Scholar 

  47. Panganiban RA, Snow AL, Day RM (2013) Mechanisms of radiation toxicity in transformed and non-transformed cells. Int J Mol Sci 14:15931–15958. https://doi.org/10.3390/ijms140815931

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Rothkamm K, Lobrich M (2003) Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci USA 100:5057–5062. https://doi.org/10.1073/pnas.0830918100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Lindsay KJ, Coates PJ, Lorimore SA, Wright EG (2007) The genetic basis of tissue responses to ionizing radiation. Br J Radiol 80:S2–S6. https://doi.org/10.1259/bjr/60507340

    Article  CAS  PubMed  Google Scholar 

  50. Surova O, Zhivotovsky B (2013) Various modes of cell death induced by DNA damage. Oncogene 32:3789–3797. https://doi.org/10.1038/onc.2012.556

    Article  CAS  PubMed  Google Scholar 

  51. Friedman EJ (2002) Immune modulation by ionizing radiation and its implications for cancer immunotherapy. Curr Pharm Des 8:1765–1780. https://doi.org/10.2174/1381612023394089

    Article  CAS  PubMed  Google Scholar 

  52. Mullins ME, Barest GD, Schaefer PW, Hochberg FH, Gonzalez RG, Lev MH (2005) Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am J Neuroradiol 26:1967–1972

    PubMed  PubMed Central  Google Scholar 

  53. Hall EJ, Brenner DJ (1993) The radiobiology of radiosurgery: rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys 25:381–385. https://doi.org/10.1016/0360-3016(93)90367-5

    Article  CAS  PubMed  Google Scholar 

  54. Ling CC, Lo YC, Larson DA (1995) Radiobiophysical aspects of stereotaxic radiation treatment of central nervous system diseases. Semin Radiat Oncol 5:192–196. https://doi.org/10.1054/SRAO00500192

    Article  CAS  PubMed  Google Scholar 

  55. Suh JH, Kotecha R, Chao ST, Ahluwalia MS, Sahgal A, Chang EL (2020) Current approaches to the management of brain metastases. Nat Rev Clin Oncol 17:279–299. https://doi.org/10.1038/s41571-019-0320-3

    Article  PubMed  Google Scholar 

  56. Jiang T, Min W, Li Y, Yue Z, Wu C, Zhou C (2016) Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta-analysis. Cancer Med 5:1055–1065. https://doi.org/10.1002/cam4.673

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Tallet AV, Dhermain F, Le Rhun E, Noel G, Kirova YM (2017) Combined irradiation and targeted therapy or immune checkpoint blockade in brain metastases: toxicities and efficacy. Ann Oncol 28:2962–2976. https://doi.org/10.1093/annonc/mdx408

    Article  CAS  PubMed  Google Scholar 

  58. Kotecha R, Kim JM, Miller JA, Juloori A, Chao ST, Murphy ES, Peereboom DM, Mohammadi AM, Barnett GH, Vogelbaum MA, Angelov L, Suh JH, Ahluwalia MS (2019) The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis. Neuro Oncol 21:1060–1068. https://doi.org/10.1093/neuonc/noz046

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Knisely JP, Yu JB, Flanigan J, Sznol M, Kluger HM, Chiang VL (2012) Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg 117:227–233. https://doi.org/10.3171/2012.5.JNS111929

    Article  PubMed  PubMed Central  Google Scholar 

  60. Schoenfeld JD, Mahadevan A, Floyd SR, Dyer MA, Catalano PJ, Alexander BM, McDermott DF, Kaplan ID (2015) Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review. J Immunother Cancer 3:50. https://doi.org/10.1186/s40425-015-0095-8

    Article  PubMed  PubMed Central  Google Scholar 

  61. Martin AM, Cagney DN, Catalano PJ, Alexander BM, Redig AJ, Schoenfeld JD, Aizer AA (2018) Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation. JAMA Oncol 4:1123–1124. https://doi.org/10.1001/jamaoncol.2017.3993

    Article  PubMed  PubMed Central  Google Scholar 

  62. Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA (2001) The role of biologically effective dose (BED) in clinical oncology. Clin Oncol R Coll Radiol 13:71–81. https://doi.org/10.1053/clon.2001.9221

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, 101, Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea

    Eun Jung Lee

  2. Department of Neurosurgery, College of Medicine, Hanyang University, 222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea

    Kyu-Sun Choi

  3. Department of Neurosurgery, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojinsunhwando-ro, Dong-gu, Ulsan, 44033, Republic of Korea

    Eun Suk Park

  4. Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympicro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea

    Young Hyun Cho

Authors
  1. Eun Jung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyu-Sun Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eun Suk Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Young Hyun Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Young Hyun Cho.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, E.J., Choi, KS., Park, E.S. et al. Single- and hypofractionated stereotactic radiosurgery for large (> 2 cm) brain metastases: a systematic review. J Neurooncol 154, 25–34 (2021). https://doi.org/10.1007/s11060-021-03805-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-021-03805-8

Keywords

Search

Navigation